| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Aug 2026 | None | ±13.8% | -34.22% | Bigger than priced |
| 2026/Q2 | 6 May 2026 | After Market | ±9.7% | -3.98% | Within range |
| 2026/Q1 | 4 Feb 2026 | After Market | ±8.3% | -11.16% | Bigger than priced |
| 2025/Q4 | 19 Nov 2025 | After Market | ±8.9% | -20.45% | Bigger than priced |
| 2025/Q3 | 6 Aug 2025 | After Market | ±11.4% | -18.82% | Bigger than priced |
| 2025/Q2 | 7 May 2025 | After Market | ±11.2% | +10.63% | Within range |
| 2025/Q1 | 5 Feb 2025 | After Market | ±12.5% | +4.02% | Within range |
| 2024/Q4 | 20 Nov 2024 | After Market | ±14.2% | +18.70% | Bigger than priced |
| 2024/Q3 | 6 Aug 2024 | After Market | ±16.4% | -3.31% | Within range |
| 2024/Q2 | 8 May 2024 | After Market | ±11.3% | -8.99% | Within range |
| 2024/Q1 | 7 Feb 2024 | After Market | ±15.7% | +10.20% | Within range |
| 2023/Q4 | 15 Nov 2023 | After Market | ±15.0% | +16.10% | Bigger than priced |
| 2023/Q3 | 8 Aug 2023 | After Market | – | -1.00% | – |
| 2023/Q2 | 9 May 2023 | After Market | ±27.2% | -3.26% | Within range |
| 2023/Q1 | 8 Feb 2023 | After Market | ±5.7% | +2.28% | Within range |
| 2022/Q4 | 12 Dec 2022 | Pre Market | ±19.6% | -17.48% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Quarter 2026/Q3
Latest reported quarter: Q3, ended Jun 2026
No comments yet — be the first to weigh in on UTI.